Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Е. L. Nasonov"'
Autor:
А. В. Borisova, Т. А. Lisitsyna, D. Yu. Veltishchev, Т. М. Reshetnyak, О. F. Seravina, О. В. Kovalevskaya, F. А. Cheldieva, А. А. Abramkin, А. Е. Zeltyn, Е. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 2, Pp 176-185 (2024)
The aim of this work is to clarify the association between the clinical and psychopathological features of mental disorders (MD) and the clinical and immunological features of antiphospholipid syndrome (APS).Material and methods. The study included 1
Externí odkaz:
https://doaj.org/article/4173f45fcc584995bb91045ad8b12d07
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 2, Pp 192-202 (2024)
Currently, methotrexate (MT) remains one of the immunosuppressive drugs most commonly used in rheumatology. However, its effect on the immunogenicity of vaccines has until recently been studied only to a limited extent, which has led to the lack of c
Externí odkaz:
https://doaj.org/article/6f9c22d60bd74a92a54c79f4015d1a88
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 2, Pp 135-144 (2024)
Glucagon-like peptide-1 receptor agonists (ArGLP-1) are effective drugs for the treatment of type 2 diabetes mellitus and obesity. Recent studies in patients with a wide range of immunoinflammatory diseases suggest important pleiotropic mechanisms of
Externí odkaz:
https://doaj.org/article/9674c9cb24dd4e93a6dc9f8abd6e49bf
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 2, Pp 186-191 (2024)
The aim of the study was to investigate the relationship between cytokine levels and values of antibodies to cyclic citrullinated peptide (anti-CCP) and antibodies to carbamylated proteins (anti-CarP) in patients with rheumatoid arthritis (RA). Mater
Externí odkaz:
https://doaj.org/article/f524914255d047bf8baca2f4c1355b31
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 1 (2022)
The aim of the work – to research the relationship between the dynamics of cytokine levels in the early period (the first 12 and 24 weeks) of pharmacotherapy for rheumatoid arthritis (RA) and long-term outcomes in patients with the disease.Material
Externí odkaz:
https://doaj.org/article/1aba47c09ab342429754e754a8676379
Autor:
M. S. Eliseev, I. Т. Vykhodets, I. V. Kruglova, M. N. Chikina, O. V. Zhelyabina, E. V. Ilyinykh, A. V. Zholinsky, S. V. Dodonov, A. M. Lila, Е. L. Nasonov
Publikováno v:
Современная ревматология, Vol 12, Iss 3, Pp 82-88 (2018)
In recent decades, the prevalence of hyperuricemia (HU) is increasing worldwide; the role of uric acid (UA) in the genesis of various metabolic disorders, cardiovascular diseases, and kidney disease is being discussed. There are very few investigatio
Externí odkaz:
https://doaj.org/article/e29fa22854a24a71b64c2baeca872c64
Autor:
E. V. Ilyinykh, Е. L. Nasonov, A. M. Lila, M. S. Eliseev, M. N. Chikina, I. Т. Vykhodets, I. V. Kruglova, A. V. Zholinsky, O. V. Zhelyabina, S. V. Dodonov
Publikováno v:
Современная ревматология, Vol 12, Iss 3, Pp 82-88 (2018)
In recent decades, the prevalence of hyperuricemia (HU) is increasing worldwide; the role of uric acid (UA) in the genesis of various metabolic disorders, cardiovascular diseases, and kidney disease is being discussed. There are very few investigatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c84ec9475a5f8fadd035795c6e46cbbf
https://mrj.ima-press.net/mrj/article/view/846
https://mrj.ima-press.net/mrj/article/view/846